Reduction of Myocardial Infarction and All-Cause Mortality Associated to Statins in Patients Without Obstructive CAD

The aim of this work was to evaluate the prognostic impact of statin therapy in symptomatic patients without obstructive CAD. Information on the prognostic impact of post–coronary computed tomographic angiography (CTA) statin use in patients with no or nonobstructive coronary artery disease (CAD) is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JACC. Cardiovascular imaging 2021-12, Vol.14 (12), p.2400-2410
Hauptverfasser:	Øvrehus, Kristian A., Diederichsen, Axel, Grove, Erik L., Steffensen, Flemming H., Mortensen, Martin B., Jensen, Jesper M., Mickley, Hans, Nielsen, Lene H., Busk, Martin, Sand, Niels Peter R., Lambrechtsen, Jess, Riis, Anders H., Andersen, Ina Trolle, Bøtker, Hans E., Nørgaard, Bjarne L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Coronary Angiography - methods Coronary Artery Disease coronary CTA Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Male Middle Aged Myocardial Infarction - etiology Predictive Value of Tests Prognosis Risk Assessment Risk Factors Severity of Illness Index statins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The aim of this work was to evaluate the prognostic impact of statin therapy in symptomatic patients without obstructive CAD. Information on the prognostic impact of post–coronary computed tomographic angiography (CTA) statin use in patients with no or nonobstructive coronary artery disease (CAD) is sparse. Patients undergoing CTA with suspected CAD in western Denmark from 2008 to 2017 with
ISSN:	1936-878X 1876-7591
DOI:	10.1016/j.jcmg.2021.05.022